Hamburg, Germany

Eckhard-Carl Albrecht Puchert

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eckhard-Carl Albrecht Puchert: Innovator in Mucosal Allergen-Specific Immunotherapy

Introduction

Eckhard-Carl Albrecht Puchert is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of immunotherapy, particularly in the area of allergen-specific treatments. His innovative approach aims to improve the quality of life for individuals suffering from seasonal allergies.

Latest Patents

Puchert holds a patent for "Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season." This invention relates to a method of administering allergen-specific immunotherapy that is initiated after the onset of the pollen season. The therapy utilizes a solid dosage form of the seasonal allergen, which is administered daily. Notably, the same dose can be maintained throughout the treatment period, eliminating the need for up-dosing.

Career Highlights

Eckhard-Carl Albrecht Puchert is associated with Alk-Abello A/S, a company known for its advancements in allergy immunotherapy. His work at the company has focused on developing innovative solutions to address the challenges faced by allergy sufferers.

Conclusion

Eckhard-Carl Albrecht Puchert's contributions to mucosal allergen-specific immunotherapy represent a significant advancement in the field of allergy treatment. His innovative patent reflects a commitment to improving patient outcomes and enhancing the effectiveness of immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…